An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis

Current Biology

Volumn 19, Issue 21, 2009, Pages 1788-1798

  Tarcic, Gabi ^a   Boguslavsky, Shlomit K ^a   Wakim, Jean ^a   Kiuchi, Tai ^b,c   Liu, Angela ^d   Reinitz, Felicia ^d   Nathanson, David ^d   Takahashi, Takamune ^e   Mischel, Paul S ^d   Ng, Tony ^b   Yarden, Yosef ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

SIGNALING

Indexed keywords

ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PTPRJ PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; UBIQUITIN PROTEIN LIGASE;

ARTICLE; BIOLOGICAL MODEL; DRUG ANTAGONISM; DRUG EFFECT; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVATION; GENETICS; HELA CELL; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ENDOCYTOSIS; ENDOSOMES; ENZYME ACTIVATION; ENZYME INHIBITORS; HELA CELLS; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 71849092111     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2009.09.048     Document Type: Article

References (46)

1. Tonks N.K. Protein tyrosine phosphatases: From genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7 (2006) 833-846
2. Citri A., and Yarden Y. EGF-ERBB signaling: Towards the systems level. Nat. Rev. Mol. Cell Biol. 7 (2006) 505-516
3. Katzmann D.J., Odorizzi G., and Emr S.D. Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 3 (2002) 893-905
4. Suarez Pestana E., Tenev T., Gross S., Stoyanov B., Ogata M., and Bohmer F.D. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells. Oncogene 18 (1999) 4069-4079
5. Flint A.J., Tiganis T., Barford D., and Tonks N.K. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 94 (1997) 1680-1685
6. Liu F., and Chernoff J. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor. Biochem. J. 327 (1997) 139-145
7. Tiganis T., Bennett A.M., Ravichandran K.S., and Tonks N.K. Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol. Cell. Biol. 18 (1998) 1622-1634
8. Reynolds A.R., Tischer C., Verveer P.J., Rocks O., and Bastiaens P.I. EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat. Cell Biol. 5 (2003) 447-453
9. Mattila E., Pellinen T., Nevo J., Vuoriluoto K., Arjonen A., and Ivaska J. Negative regulation of EGFR signaling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. Nat. Cell Biol. 7 (2005) 78-85
10. Xu Y., Tan L.J., Grachtchouk V., Voorhees J.J., and Fisher G.J. Receptor-type protein-tyrosine phosphatase-kappa regulates epidermal growth factor receptor function. J. Biol. Chem. 280 (2005) 42694-42700
11. Ostman A., Yang Q., and Tonks N.K. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. Proc. Natl. Acad. Sci. USA 91 (1994) 9680-9684
12. Ruivenkamp C.A., van Wezel T., Zanon C., Stassen A.P., Vlcek C., Csikos T., Klous A.M., Tripodis N., Perrakis A., Boerrigter L., et al. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat. Genet. 31 (2002) 295-300
13. Iuliano R., Trapasso F., Le Pera I., Schepis F., Sama I., Clodomiro A., Dumon K.R., Santoro M., Chiariotti L., Viglietto G., et al. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. Cancer Res. 63 (2003) 882-886
14. Keane M.M., Lowrey G.A., Ettenberg S.A., Dayton M.A., and Lipkowitz S. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res. 56 (1996) 4236-4243
15. Trapasso F., Iuliano R., Boccia A., Stella A., Visconti R., Bruni P., Baldassarre G., Santoro M., Viglietto G., and Fusco A. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1). Mol. Cell. Biol. 20 (2000) 9236-9246
16. Trapasso F., Yendamuri S., Dumon K.R., Iuliano R., Cesari R., Feig B., Seto R., Infante L., Ishii H., Vecchione A., et al. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. Carcinogenesis 25 (2004) 2107-2114
17. Grazia Lampugnani M., Zanetti A., Corada M., Takahashi T., Balconi G., Breviario F., Orsenigo F., Cattelino A., Kemler R., Daniel T.O., et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J. Cell Biol. 161 (2003) 793-804
18. Jandt E., Denner K., Kovalenko M., Ostman A., and Bohmer F.D. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion. Oncogene 22 (2003) 4175-4185
19. Palka H.L., Park M., and Tonks N.K. Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1. J. Biol. Chem. 278 (2003) 5728-5735
20. Mosesson Y., Chetrit D., Schley L., Berghoff J., Ziv T., Carvalho S., Milanezi F., Admon A., Schmitt F., Ehrlich M., et al. Monoubiquitylation regulates endosomal localization of Lst2, a negative regulator of EGF receptor signaling. Dev. Cell 16 (2009) 687-698
21. Gordon J.A. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 201 (1991) 477-482
22. Onoda T., Iinuma H., Sasaki Y., Hamada M., Isshiki K., Naganawa H., Takeuchi T., Tatsuta K., and Umezawa K. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus. J. Nat. Prod. 52 (1989) 1252-1257
23. Berset T.A., Hoier E.F., and Hajnal A. The C. elegans homolog of the mammalian tumor suppressor Dep-1/Scc1 inhibits EGFR signaling to regulate binary cell fate decisions. Genes Dev. 19 (2005) 1328-1340
24. Lai W.H., Cameron P.H., Doherty II J.J., Posner B.I., and Bergeron J.J. Ligand-mediated autophosphorylation activity of the epidermal growth factor receptor during internalization. J. Cell Biol. 109 (1989) 2751-2760
25. Goldman R., Levy R.B., Peles E., and Yarden Y. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: A mechanism for receptor transregulation. Biochemistry 29 (1990) 11024-11028
26. Legg J.W., Lewis C.A., Parsons M., Ng T., and Isacke C.M. A novel PKC-regulated mechanism controls CD44 ezrin association and directional cell motility. Nat. Cell Biol. 4 (2002) 399-407
27. Ng T., Squire A., Hansra G., Bornancin F., Prevostel C., Hanby A., Harris W., Barnes D., Schmidt S., Mellor H., et al. Imaging protein kinase Calpha activation in cells. Science 283 (1999) 2085-2089
28. Barber P.R., Ameer-Beg S.M., Gilbey J., Carlin L.M., Keppler M., Ng T.C., and Vojnovic B. Multiphoton time-domain fluorescence lifetime imaging microscopy: Practical application to protein-protein interactions using global analysis. J. R. Soc. Interface 6 (2009) S93-S105
29. Levkowitz G., Waterman H., Ettenberg S.A., Katz M., Tsygankov A.Y., Alroy I., Lavi S., Iwai K., Reiss Y., Ciechanover A., et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell 4 (1999) 1029-1040
30. Waterman H., and Yarden Y. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Lett. 490 (2001) 142-152
31. Feshchenko E.A., Langdon W.Y., and Tsygankov A.Y. Fyn, Yes, and Syk phosphorylation sites in c-Cbl map to the same tyrosine residues that become phosphorylated in activated T cells. J. Biol. Chem. 273 (1998) 8323-8331
32. Pera I.L., Iuliano R., Florio T., Susini C., Trapasso F., Santoro M., Chiariotti L., Schettini G., Viglietto G., and Fusco A. The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. Oncogene 24 (2005) 3187-3195
33. Iervolino A., Iuliano R., Trapasso F., Viglietto G., Melillo R.M., Carlomagno F., Santoro M., and Fusco A. The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. Cancer Res. 66 (2006) 6280-6287
34. Polo S., and Di Fiore P.P. Endocytosis conducts the cell signaling orchestra. Cell 124 (2006) 897-900
35. Kovalenko M., Denner K., Sandstrom J., Persson C., Gross S., Jandt E., Vilella R., Bohmer F., and Ostman A. Site-selective dephosphorylation of the platelet-derived growth factor beta-receptor by the receptor-like protein-tyrosine phosphatase DEP-1. J. Biol. Chem. 275 (2000) 16219-16226
36. Miaczynska M., Christoforidis S., Giner A., Shevchenko A., Uttenweiler-Joseph S., Habermann B., Wilm M., Parton R.G., and Zerial M. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116 (2004) 445-456
37. Zhang L., Martelli M.L., Battaglia C., Trapasso F., Tramontano D., Viglietto G., Porcellini A., Santoro M., and Fusco A. Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase. Exp. Cell Res. 235 (1997) 62-70
38. Ruivenkamp C., Hermsen M., Postma C., Klous A., Baak J., Meijer G., and Demant P. LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene 22 (2003) 3472-3474
39. Iuliano R., Le Pera I., Cristofaro C., Baudi F., Arturi F., Pallante P., Martelli M.L., Trapasso F., Chiariotti L., and Fusco A. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Oncogene 23 (2004) 8432-8438
40. Sacco F., Tinti M., Palma A., Ferrari E., Nardozza A.P., Hooft van Huijsduijnen R., Takahashi T., Castagnoli L., and Cesareni G. Tumor suppressor density-enhanced phosphatase-1 (DEP-1) inhibits the RAS pathway by direct dephosphorylation of ERK1/2 kinases. J Biol Chem. 284 (2009) 22048-22058
41. Di Guglielmo G.M., Baass P.C., Ou W.J., Posner B.I., and Bergeron J.J. Compartmentalization of SHC, GRB2 and mSOS, and hyperphosphorylation of Raf-1 by EGF but not insulin in liver parenchyma. EMBO J. 13 (1994) 4269-4277
42. Sorkin A., Eriksson A., Heldin C.H., Westermark B., and Claesson-Welsh L. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization. J. Cell. Physiol. 156 (1993) 373-382
43. Tsuboi N., Utsunomiya T., Roberts R.L., Ito H., Takahashi K., Noda M., and Takahashi T. The tyrosine phosphatase CD148 interacts with p85 regulatory subunit of phosphoinositide 3-kinase. Biochem J. 413 (2008) 193-200
44. Katz M., Shtiegman K., Tal-Or P., Yakir L., Mosesson Y., Harari D., Machluf Y., Asao H., Jovin T., Sugamura K., et al. Ligand-independent degradation of epidermal growth factor receptor involves receptor ubiquitylation and Hgs, an adaptor whose ubiquitin-interacting motif targets ubiquitylation by Nedd4. Traffic 3 (2002) 740-751
45. Zwang Y., and Yarden Y. p38 MAP kinase mediates stress-induced internalization of EGFR: Implications for cancer chemotherapy. EMBO J. 25 (2006) 4195-4206
46. Peter M., Ameer-Beg S.M., Hughes M.K., Keppler M.D., Prag S., Marsh M., Vojnovic B., and Ng T. Multiphoton-FLIM quantification of the EGFP-mRFP1 FRET pair for localization of membrane receptor-kinase interactions. Biophys. J. 88 (2005) 1224-1237